
Overview
Synerga.Fund S.A. is a Kraków-based joint-stock company listed on the GPW NewConnect market under the ticker SNG. The company operates in the field of cell therapies. It also publishes basic registration and capital data, as well as reporting and corporate documents.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $10,237 |
Filing timeliness
Financial statements were filed on time, on average 30 days early. All were audited by a statutory auditor.
- 202508/07/2026
- 202422/05/2025
- 202302/07/2024
- 202213/07/2023
- 202108/07/2022
- 202013/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 0.36
- High
- PLN 0.36
- Low
- PLN 0.36
- Volume
- 6.53K
- Avg. vol.
- 6.32K
- Market cap
- PLN 9.83M
- P/E ratio
- –
- EPS
- -PLN 0.04
- Shares outstanding
- 27.31M
- 52-week
- PLN 0.35 – 0.40
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLMWTNS00010
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q3 2026 | USD 4.05k | USD -6.75k | USD -6.75k |
| Q2 2026 | USD -40.52k | USD -2.97k | USD -3.24k |
| Q1 2026 | USD 29.71k | USD -6.48k | USD -6.48k |
| Q4 2025 | USD 18.83k | USD -16.07k | USD -16.32k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The following are authorized to submit declarations of will on behalf of the company and sign declarations on behalf of the company: - the President of the Management Board acting independently; or - two members of the management board acting jointly; or - one member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
Synerga.Fund is a public company listed on NewConnect, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Bank accounts
Registered as a VAT taxpayer on 2010-10-22.
92 1020 2906 0000 1002 0376 4073
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 8, 2020 | Call to creditors | |
| Sep 5, 2019 | Call to creditors | |
| Dec 29, 2011 | Commercial Companies Code notice | |
| Dec 6, 2011 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Just Be Innovative sp. z o.o. | $32,662.40 | justbeinnovative.com | ||
| DR Joanna Sanford sp. k. | $28,674.82 | sanfordbiotech.com | ||
| Cellis sp. z o.o. | $24,935.59 | cellis.eu | ||
| 4cell Therapies S.A. | $9,123.06 | 4celltherapies.com | ||
| Thesybin Labs P.S.A. | $8,297.34 | thesybin.pl | ||
| Oncotherics Poland S.A. | $7,565.33 | oncotherics.com | ||
| Bioinfobank Capital sp. z o.o. | $6,252.45 | bioinfo.pl | ||
| Fusiomica sp. z o.o. | $5,263.98 | fusiomica.com | ||
| Spinbionic sp. z o.o. | $3,516.36 | spinbionic.com | ||
| Passio Human Microbiome sp. z o.o. | $1,856.58 | passiohumanmicrobiome.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-30 | Address change (Ul. Grzegórzecka 67d/26, 31-559, Kraków → Ul. Mogilska 65, 31-545, Kraków) | |
| 2020-10-07 | Share capital reduction (2,731,000.00 PLN → 2,730,999.00 PLN) | |
| 2019-12-13 | Share capital reduction (27,310,000.00 PLN → 2,731,000.00 PLN) | |
| 2019-11-21 | Address change (Ul. Malwowa 30, 30-611, Kraków → Ul. Grzegórzecka 67d/26, 31-559, Kraków) | |
| 2017-08-17 | Address change (Ul. Franciszka Klimczaka 17/80, 02-797, Warszawa → Ul. Malwowa 30, 30-611, Kraków) |
FAQ
Last updated: 2026-10-30